Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MDM2 splice variants and their therapeutic implications.

L C Harris1

  • 1Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38112, USA. linda.harris@stjude.org

Current Cancer Drug Targets
|February 22, 2005
PubMed
Summary

MDM2 splice variants are linked to cancer progression but have contradictory functions. Their role in tumor development and as therapeutic targets requires further investigation due to complex p53 interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective review of an epidural blood patch database: the incidence of epidural blood patch associated with obstetric neuraxial anesthetic techniques and the effect of blood volume on efficacy.

International journal of obstetric anesthesia·2016
Same author

The relationship of cardiac glycogen deposition to blood ketone levels in experimental ketosis.

The American journal of physiology·2010
Same author

Multiple necroses of the spleen (fleckmilz).

The American journal of pathology·2009
Same author

Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression.

Cell death and differentiation·2007
Same author

Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients.

Oncogene·2007
Same author

Ocular pharmacology of bicyclic hexahydroaporphines.

Methods and findings in experimental and clinical pharmacology·2005

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MDM2 splice variants are found in various tumors and linked to advanced disease.
  • Their precise role in tumorigenesis and therapeutic potential remains unclear due to conflicting data.

Purpose of the Study:

  • To investigate the contradictory functions of MDM2 splice variants in cancer.
  • To explore the mechanisms underlying MDM2 splice variant-mediated effects on tumor development and cell growth.

Main Methods:

  • Utilized transgenic mouse models (MDM2-B and Emu-myc) to study splice variant expression in vivo.
  • Conducted in vitro experiments to assess the impact of splice variants on cell growth and p53 interactions.

Main Results:

Related Experiment Videos

  • In vivo studies showed MDM2 splice variants promote tumor development.
  • In vitro, splice variants induced p53-dependent growth inhibition by binding to full-length MDM2, increasing p53 activity.
  • This suggests potential p53 inactivation or apoptosis contributing to in vivo tumorigenesis.

    • Conclusions:

    • MDM2 splice variants exhibit complex, context-dependent roles in cancer.
    • Their therapeutic potential as targets may vary based on their specific phenotype in different tumor types.
    • Further research is needed to elucidate both p53-dependent and independent activities.